ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
36.42
0.00%
US Tech 100
18,090.80
0.80%
S&P 500
5,408.42
-1.73%
US Dollar vs CAD
1.35681
0.04%
Bitcoin
55,224.53
0.67%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. Clene Inc (CLNN) Share Price

Clene Inc

Clene Inc (CLNN)

NASDAQ
5.93
-0.38
(-6.02%)
Closed September 06 3:00PM
Delayed by 15 minutes
5.93
0.00
( 0.00% )
Pre Market: 5:13AM
Delayed by 15 minutes

Empower your portfolio: Real-time discussions and actionable trading ideas.

Premium

Key stats and details

Current Price
5.93
Bid
4.60
Ask
6.28
Volume
-
0.00 Day's Range 0.00
3.8181 52 Week Range 14.00
Market Cap
38.367M
Previous Close
5.93
Open
-
Last Trade
Last Trade Time
-
Financial Volume
-
VWAP
-
Average Volume (3m)
308,289
Shares Outstanding
6,470,067
Dividend Yield
-
PE Ratio
-0.78
Earnings Per Share (EPS)
-7.65
Revenue
654k
Net Profit
-49.5M

About Clene Inc

Clene Inc is a clinical-stage pharmaceutical company pioneering the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. It is focused on the development of therapeutics for neurodegenerative diseases. Its reportable segments: (1) the development a... Clene Inc is a clinical-stage pharmaceutical company pioneering the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. It is focused on the development of therapeutics for neurodegenerative diseases. Its reportable segments: (1) the development and commercialization of novel clean-surfaced nanotechnology therapeutics (Drugs, and (2) the development and commercialization of dietary supplements (Supplements). Show more

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
www.clene.com
Headquarters
Dover, Delaware, USA
Founded
-
Clene Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker CLNN. The last closing price for Clene was US$5.93. Over the last year, Clene shares have traded in a share price range of US$ 3.8181 to US$ 14.00.

Clene currently has 6,470,067 shares outstanding. The market capitalization of Clene is US$38.37 million. Clene has a price to earnings ratio (PE ratio) of -0.78.

Ask ADVFN Intelligence (AI)

CLNN Latest News

More News

Form 4 - Statement of changes in beneficial ownership of securities

August 19 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

August 19 2024
Edgar (US Regulatory)

IBN Announces Latest Episode of The BioMedWire Podcast featuring Rob Etherington, CEO of Clene Inc.

LOS ANGELES, Aug. 08, 2024 (GLOBE NEWSWIRE) -- via IBN – IBN, a multifaceted communications organization engaged in connecting public companies to the investment community, is pleased to...

August 08 2024
GlobeNewswire Inc.

Form 8-K - Current report

August 07 2024
Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

August 07 2024
Edgar (US Regulatory)

Form 8-K - Current report

August 06 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

July 30 2024
Edgar (US Regulatory)

Form 8-K - Current report

July 26 2024
Edgar (US Regulatory)

Form 8-K - Current report

July 11 2024
Edgar (US Regulatory)

Form 8-K - Current report

July 09 2024
Edgar (US Regulatory)
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.6111.46616541355.326.95.321191536.23165314CS
40.8316.27450980395.16.94.7741845.61497138CS
12-1.686-22.1376050427.6168.3963.81813082896.26208335CS
26-4.07-40.71010.1963.81815861847.05732548CS
52-8.07-57.642857142914143.81816824067.74718655CS
156-149.67-96.1889460154155.61623.818155240233.16926852CS
260-191.47-96.9959473151197.4356.43.818150431654.66199908CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
INBSIntelligent Bio Solutions Inc
US$ 2.79
(76.58%)
6.63M
TNXPTonix Pharmaceuticals Holding Corporation
US$ 0.2275
(59.65%)
42.06M
SMMTSummit Therapeutics Inc
US$ 18.33
(49.39%)
1.5M
VIAVViavi Solutions Inc
US$ 11.00
(39.06%)
42
IVPInspire Veterinary Partners Inc
US$ 1.10
(26.07%)
3.93M
WHLRWheeler Real Estate Investment Trust Inc
US$ 8.41
(-17.95%)
558.06k
CCCCC4 Therapeutics Inc
US$ 4.48
(-17.04%)
59.18k
BENFBeneficient
US$ 1.76
(-14.15%)
165.52k
DSYBig Tree Cloud Holdings Limited
US$ 3.71
(-14.12%)
774
BMRABiomerica Inc
US$ 0.3007
(-13.34%)
612
TNXPTonix Pharmaceuticals Holding Corporation
US$ 0.2275
(59.65%)
42.06M
INBSIntelligent Bio Solutions Inc
US$ 2.79
(76.58%)
6.63M
IVPInspire Veterinary Partners Inc
US$ 1.10
(26.07%)
3.93M
WTOUTime Limited
US$ 0.06175
(-6.44%)
3.86M
SQQQProShares UltraPro Short QQQ
US$ 9.485
(-2.42%)
2.29M

CLNN Discussion

View Posts
Awl416 Awl416 1 month ago
Damn
👍️0
Termite7 Termite7 4 months ago
Lower please.....thanks!!!
👍️0
Awl416 Awl416 5 months ago
Pop
👍️0
Monksdream Monksdream 6 months ago
CLNN 10Q due March 8
👍️0
Monksdream Monksdream 9 months ago
CLNN new 52 week low
👎️ 1 🩳 1
scotsand scotsand 9 months ago
Running now. Join the fun.
👍️0
Monksdream Monksdream 10 months ago
CLNN new 52 week low
👍️0
Monksdream Monksdream 12 months ago
CLNN new 52 week low
👍️0
Monksdream Monksdream 12 months ago
CLNN new 52 week low
👍️0
Monksdream Monksdream 12 months ago
CLNN new 52 week low
👍️0
Louman Louman 1 year ago
7 analyst ratings still 100% buy. PT $4-$10.
👍️0
Louman Louman 1 year ago
$3.4 million in inside buys between 6-20 and 6-27. Price target $5. 7 analyst ratings 100% buy
👍️0
bwrbad bwrbad 1 year ago
THIS IS ONE ISSUE DO NOT MISS
👍️0
JUST 10-11-12 JUST 10-11-12 2 years ago
i.ll take 12 bucks per share
👍️0
CapGainsman CapGainsman 2 years ago
EF Hutton initiates coverage today on CLNN with a $13 price target. And HC Wainwright has reiterated a $15 price target twice in recent days. And CLNN has reported positive trial results in recent weeks. Other than there appear to be a bunch of pesky shorters involved, this seems like a gift down here. Also, CLNN will be presenting in the upcoming Roth's 35th annual healthcare conference.
👍️0
81vette 81vette 2 years ago
12mms stacked,bid/demand growing,13k@1.21,could pop any min now
👍️0
81vette 81vette 2 years ago
Over 3m shares short,some covering has to happen
👍️0
81vette 81vette 2 years ago
Day1 of higher high/higher low,gotta love nabbing the very beginning of bulls being turned loose,market is manipulated the worst in 20 years,mms/banks have gotten ridiculously greedy,can’t beat em/join um is my motto
👍️0
81vette 81vette 2 years ago
My Scanner telling me buy now,bulls back to loading for run again
👍️0
skichic skichic 2 years ago
Oppenheimer has a buy rating of Overweight for CLNN and a price target of $20.00!
👍️0
skichic skichic 2 years ago
Strange how CLNN traded today. Fantastic news, huge insider buy and the shorts controlled. Absolutely crazy. I added to my stash big time!
👍️0
81vette 81vette 2 years ago
Bills have to get paid,maybe done in after mkt for continued this year long up trend,
👍️0
TheFinalCD TheFinalCD 2 years ago
ALL DAY FADER= ZZZZZZZZZ
👍️0
81vette 81vette 2 years ago
todays news>https://capedge.com/news/benzinga/30873738/clene-reports-new-data?fromCompany=1822791
👍️0
81vette 81vette 2 years ago
zero borrow>no shares available to short(float locked up),insider buys up 400%,recient news coverage blowing up,283Xs ave vol will get attention today
👍️0
81vette 81vette 2 years ago
#1 on my scanner>Strong Volume Gainer,New CCI Buy Signals,Parabolic SAR Buy Signals,Gap Ups,Filled Black Candles,Elder Bar Turned Green
👍️0
81vette 81vette 2 years ago
#1 on my scanner>Strong Volume Gainer,New CCI Buy Signals,Parabolic SAR Buy Signals,Gap Ups,Filled Black Candles,Elder Bar Turned Green
👍️0
81vette 81vette 2 years ago
Shares Outstanding 63.51M,Shares Float 27.20M,Institutional Ownership 6.00%,Insider Ownership 8.80%,Short Float 6.74%
👍️0
harry crumb harry crumb 2 years ago
Any reason this is active other than form 4’s filed? Their lead science candidate failed
👍️0
tw0122 tw0122 2 years ago
At least you got the board opened flipped it once already when it went under $2 $1.95 to $2.17. Maybe will try one more time on a pullback..
👍️0
TheFinalCD TheFinalCD 2 years ago
https://clene.com/pipeline/
👍️0
TheFinalCD TheFinalCD 2 years ago
https://finviz.com/quote.ashx?t=CLNN&ty=c&ta=1&p=d
👍️0

Your Recent History

NASDAQ
CLNN
Clene
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved